Search Results 561-570 of 23425 for B cell lymphomas
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy ... Durvalumab is FDA approved for treatment in lung cancers including non-small cell ...
It is also used in combination with other cancer medicines to treat mature B-cell non-Hodgkin's lymphoma (NHL) and mature B-cell acute leukemia (B-AL). It ...
... cells, either by killing the cells or by stopping them from dividing ... B or C or active hepatitis; Major surgery within 2 ... Peripheral T-cell lymphomas (PTCL) ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
CAR-T cell therapy, B-cell lymphoma, Lymphoma, T-cell lymphoma, Cutaneous t-cell lymphoma, Follicular lymphoma · Thomas F ...
Brooke's diagnosis: primary B-cell lymphoma, a cancer of the immune system that tends to affect young people. "Cancer — when you get that diagnosis ...
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Pagination Clinical studies. PrevPrevious ...
About this study. Given that family members of CLL patients are known to have an increased risk of CLL (on the order of 8-fold), and they have a higher ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.